HU205073B - Process for producing 1,4-disubstituted-piperidinyl diketone derivatives and pharmaceutical compositions comprising same as active ingredient - Google Patents
Process for producing 1,4-disubstituted-piperidinyl diketone derivatives and pharmaceutical compositions comprising same as active ingredient Download PDFInfo
- Publication number
- HU205073B HU205073B HU90238A HU23890A HU205073B HU 205073 B HU205073 B HU 205073B HU 90238 A HU90238 A HU 90238A HU 23890 A HU23890 A HU 23890A HU 205073 B HU205073 B HU 205073B
- Authority
- HU
- Hungary
- Prior art keywords
- piperidinyl
- acid
- formula
- compounds
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14664788A | 1988-01-21 | 1988-01-21 | |
| US07/279,900 US5064838A (en) | 1988-01-21 | 1988-12-07 | 1,4-disubstituted-piperidinyl compounds as pain relievers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU900238D0 HU900238D0 (en) | 1990-03-28 |
| HUT53871A HUT53871A (en) | 1990-12-28 |
| HU205073B true HU205073B (en) | 1992-03-30 |
Family
ID=48782796
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU89189A HU202494B (en) | 1988-01-21 | 1989-01-18 | Process for producing 1,4-disubstituted piperidinyl derivatives and pharmaceutical compositions containing them |
| HU90238A HU205073B (en) | 1988-01-21 | 1989-01-18 | Process for producing 1,4-disubstituted-piperidinyl diketone derivatives and pharmaceutical compositions comprising same as active ingredient |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU89189A HU202494B (en) | 1988-01-21 | 1989-01-18 | Process for producing 1,4-disubstituted piperidinyl derivatives and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5064838A (es) |
| EP (1) | EP0325268B1 (es) |
| JP (1) | JP2967990B2 (es) |
| KR (1) | KR0131377B1 (es) |
| CN (1) | CN1035823A (es) |
| AR (2) | AR247385A1 (es) |
| AT (1) | ATE90077T1 (es) |
| AU (1) | AU615713B2 (es) |
| CA (1) | CA1330087C (es) |
| DE (1) | DE68906801T2 (es) |
| DK (1) | DK26389A (es) |
| ES (1) | ES2058346T3 (es) |
| FI (1) | FI90534C (es) |
| HU (2) | HU202494B (es) |
| NO (1) | NO174505B (es) |
| NZ (1) | NZ227643A (es) |
| PH (1) | PH27115A (es) |
| PT (1) | PT89497B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
| NZ236501A (en) * | 1989-12-21 | 1992-12-23 | Merrell Dow Pharma | Piperidine derivatives and antithrombotic compositions |
| US5292752A (en) * | 1989-12-21 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Antithrombotic compounds |
| DK0531410T3 (da) * | 1990-06-01 | 1995-01-30 | Merrell Dow Pharma | (+)-alfa-(2,3-Demethoxyphenyl)-1-(2-(4-fluorphenyl)ethyl)-4-piperidinmethanol |
| CA2084082C (en) * | 1990-06-07 | 2002-03-19 | Albert A. Carr | 1-pyperidinyl alkanoylarysulfonamide derivatives |
| FR2672286B1 (fr) * | 1991-01-31 | 1994-11-18 | Synthelabo | Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique. |
| US5292726A (en) * | 1991-05-22 | 1994-03-08 | Merck & Co., Inc. | N,N-diacylpiperazines |
| FR2678269B1 (fr) * | 1991-06-27 | 1995-01-13 | Synthelabo | Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique. |
| US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5637699A (en) * | 1992-06-29 | 1997-06-10 | Merck & Co., Inc. | Process for preparing morpholine tachykinin receptor antagonists |
| US6048859A (en) | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
| US5387595A (en) * | 1992-08-26 | 1995-02-07 | Merck & Co., Inc. | Alicyclic compounds as tachykinin receptor antagonists |
| FR2696741B1 (fr) * | 1992-10-12 | 1994-11-25 | Synthelabo | Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique. |
| US5344830A (en) * | 1992-12-10 | 1994-09-06 | Merck & Co., Inc. | N,N-diacylpiperazine tachykinin antagonists |
| US5348955A (en) * | 1993-06-22 | 1994-09-20 | Merck & Co., Inc. | N,N-diacylpiperazines |
| US5610165A (en) * | 1994-02-17 | 1997-03-11 | Merck & Co., Inc. | N-acylpiperidine tachykinin antagonists |
| IL112778A0 (en) * | 1994-03-04 | 1995-05-26 | Merck & Co Inc | Substituted heterocycles, their preparation and pharmaceutical compositions containing them |
| EP0796619A1 (en) * | 1996-03-21 | 1997-09-24 | Merrell Pharmaceuticals Inc. | Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| US6028083A (en) * | 1997-07-25 | 2000-02-22 | Hoechst Marion Roussel, Inc. | Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol |
| CA2276373C (en) | 1997-10-31 | 2010-01-12 | Suntory Limited | Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| US20050261341A1 (en) * | 1998-03-13 | 2005-11-24 | Aventis Pharmaceuticals Inc. | Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| US6713627B2 (en) * | 1998-03-13 | 2004-03-30 | Aventis Pharmaceuticals Inc. | Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| US6939879B2 (en) * | 1998-08-28 | 2005-09-06 | Aventis Pharmaceuticals Inc. | Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia |
| US6277864B1 (en) | 1998-08-28 | 2001-08-21 | Aventis Pharmaceuticals Inc. | Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3576810A (en) * | 1968-06-20 | 1971-04-27 | Robins Co Inc A H | 1-substituted-3-(-4)-aroylpiperidines |
| GB1402889A (en) * | 1973-02-03 | 1975-08-13 | Ciba Geigy Ag | Piperidine derivatives |
| FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
| KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
-
1988
- 1988-12-07 US US07/279,900 patent/US5064838A/en not_active Expired - Fee Related
-
1989
- 1989-01-16 CA CA000588352A patent/CA1330087C/en not_active Expired - Fee Related
- 1989-01-17 NZ NZ227643A patent/NZ227643A/xx unknown
- 1989-01-17 FI FI890245A patent/FI90534C/fi not_active IP Right Cessation
- 1989-01-18 HU HU89189A patent/HU202494B/hu not_active IP Right Cessation
- 1989-01-18 HU HU90238A patent/HU205073B/hu not_active IP Right Cessation
- 1989-01-19 AR AR89313027A patent/AR247385A1/es active
- 1989-01-20 AU AU28687/89A patent/AU615713B2/en not_active Ceased
- 1989-01-20 PH PH38074A patent/PH27115A/en unknown
- 1989-01-20 AT AT89100955T patent/ATE90077T1/de not_active IP Right Cessation
- 1989-01-20 PT PT89497A patent/PT89497B/pt not_active IP Right Cessation
- 1989-01-20 DK DK026389A patent/DK26389A/da not_active Application Discontinuation
- 1989-01-20 ES ES89100955T patent/ES2058346T3/es not_active Expired - Lifetime
- 1989-01-20 KR KR1019890000597A patent/KR0131377B1/ko not_active IP Right Cessation
- 1989-01-20 DE DE8989100955T patent/DE68906801T2/de not_active Expired - Fee Related
- 1989-01-20 NO NO890269A patent/NO174505B/no unknown
- 1989-01-20 EP EP89100955A patent/EP0325268B1/en not_active Expired - Lifetime
- 1989-01-20 JP JP1013022A patent/JP2967990B2/ja not_active Expired - Fee Related
- 1989-01-21 CN CN89100339A patent/CN1035823A/zh active Pending
- 1989-05-09 AR AR89313868A patent/AR244666A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| AR244666A1 (es) | 1993-11-30 |
| KR0131377B1 (ko) | 1998-04-17 |
| US5064838A (en) | 1991-11-12 |
| NO174505B (no) | 1994-02-07 |
| HU202494B (en) | 1991-03-28 |
| AU615713B2 (en) | 1991-10-10 |
| ATE90077T1 (de) | 1993-06-15 |
| DE68906801D1 (de) | 1993-07-08 |
| DK26389D0 (da) | 1989-01-20 |
| FI90534C (fi) | 1994-02-25 |
| ES2058346T3 (es) | 1994-11-01 |
| NO174505C (es) | 1994-05-18 |
| NO890269L (no) | 1989-07-24 |
| NZ227643A (en) | 1991-01-29 |
| JPH01224360A (ja) | 1989-09-07 |
| FI890245A0 (fi) | 1989-01-17 |
| AR247385A1 (es) | 1994-12-29 |
| FI890245A (fi) | 1989-07-22 |
| CA1330087C (en) | 1994-06-07 |
| EP0325268B1 (en) | 1993-06-02 |
| PT89497B (pt) | 1994-03-31 |
| HU900238D0 (en) | 1990-03-28 |
| DE68906801T2 (de) | 1993-09-23 |
| KR890011840A (ko) | 1989-08-22 |
| NO890269D0 (no) | 1989-01-20 |
| AU2868789A (en) | 1989-07-27 |
| DK26389A (da) | 1989-07-22 |
| EP0325268A1 (en) | 1989-07-26 |
| PH27115A (en) | 1993-03-16 |
| PT89497A (pt) | 1989-10-04 |
| FI90534B (fi) | 1993-11-15 |
| HUT52050A (en) | 1990-06-28 |
| HUT53871A (en) | 1990-12-28 |
| CN1035823A (zh) | 1989-09-27 |
| JP2967990B2 (ja) | 1999-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU205073B (en) | Process for producing 1,4-disubstituted-piperidinyl diketone derivatives and pharmaceutical compositions comprising same as active ingredient | |
| CZ391091A3 (en) | Crystalline paroxetin hydrochloride hemihydrate, process for producing thereof and pharmaceutical preparations in which it is comprised | |
| HU199425B (en) | Process for producing alpha-alkyl-/4-amino-3-quinolinyl/-methanols and 1-square brackets open 4-/aralkylamino/-3-quinolinyl square brackets closed -alkanones, as well as pharmaceutical compositions comprising such compounds as active ingredient | |
| US4246268A (en) | Neuroleptic-4-(naphthylmethyl)piperidine derivatives | |
| US4224329A (en) | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles | |
| US4284635A (en) | Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines | |
| WO1992002501A1 (en) | 3-substituted piperidine derivatives | |
| JPH01197469A (ja) | ピペリジニル化合物類 | |
| HU199793B (en) | Process for producing 1,4-disubstituted piperidinyl derivatives | |
| US4061769A (en) | Method and composition for treating hypertension | |
| FR2793245A1 (fr) | Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| HU187480B (en) | Process for producing 1-bracket-4-quinolyl-bracket closed-2-bracket-4-piperidyl-bracket closed-ethanol and 1-bracket-4-quinolyl-bracket closed-3-bracket-4-piperidiyl-bracket closed-propanol and pharmaceutival compositions containing them as active agents | |
| HU185432B (en) | Process for producing indene derivatives | |
| US4689329A (en) | 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates | |
| US5162342A (en) | Use of 1,4-disubstituted-piperidinyl compounds for analgesia and muscle relaxation | |
| JPH02124885A (ja) | イミダゾール抗不整脈剤 | |
| US4716172A (en) | 4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates | |
| US4252812A (en) | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles | |
| EP1050530B1 (fr) | 1-Aza-2-Alkyl-6-Aryl-Cycloalcanes utiles pour améliorer la mémoire | |
| IE62991B1 (en) | 1,4-disubstituted-piperidinyl compounds | |
| US4277404A (en) | 5-(4-Fluorophenyl)tetrahydro-2-furanol | |
| US5608069A (en) | 1-substituted, 3-carboxylic acid piperidine derivatives | |
| CA2272453A1 (fr) | Benzoylalkyl-1,2,3,6-tetrahydropyridines | |
| NZ227018A (en) | 1,4 disubstituted piperidine derivatives and pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |